CDSCO rejects Cipla’s application for marketing US-based MannKind Corporation’s inhaled insulin, branded Afrezza; Local climical trial is compulsory
An expert panel of the Central Drugs Standard Control Organisation (CDSCO) has insisted that a local clinical trial should be compulsorily conducted... Read More